Genentech has announced plans to invest more than $700 million in a new 700,000 square foot drug manufacturing facility.

Piramal Pharma Limited has committed to a $90 million investment plan towards expanding two of its U.S. facilities.

Advanced analytics leverages machine learning (ML), statistical modeling, data mining and visualizations to empower ...

Dr. Conrad brings over 30 years of experience spanning R&D, strategy and operations, business and corporate development, ...

Ratio has entered into an agreement with Wasatch Group to partner and construct a radiopharmaceutical research and ...

Andelyn Biosciences Inc. successfully manufactured a novel viral vector gene therapy to treat a baby with the ultra-rare ...

Vetter has announced that Managing Director Peter Soelkner will step down from his role to pursue new challenges outside of ...

The pharmaceutical service provider publishes its 2024 Sustainability Report.

Nelson Labs Nina Moreno shares insight on rapid sterility testing, the technologies used, advantages, and regulatory ...

An integrated supply chain partner can reduce risk, enable scalability, and preserve capital in today’s volatile market.

Unlock the full potential of poorly soluble compounds with Spray Dried Dispersions (SDDs). This webinar will explore key ...

Gilead Sciences is investing an additional $11 billion into its U.S. operations, the company announced this week, bringing ...